Purpose: This systematic review aims to evaluate the utility of mobile health (mHealth) applications in uro-oncology, hereafter referred to as mHealth apps, specifically examining their potential to improve patient care, symptom management, and communication in genitourinary cancer treatment.Methods: Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive systematic review was conducted focusing on mHealth applications for patients with genitourinary cancers.Results: The review analyzed 29 studies, which revealed that mHealth apps demonstrated potential in uro-oncology patient care. Key findings included effective symptom monitoring, enhanced decision support, and improved patient education. The applications were found to be feasible and well-accepted by patients. However, implementation challenges were identified, including technical barriers, variations in app quality, and unequal access to digital healthcare technologies. This review systematically categorized mHealth interventions into three functional domains—symptom management, decision support, and personalized care—and identified critical implementation barriers including digital inequity, high risk of bias, and app quality variability.Conclusions: Mobile health applications demonstrate promise in revolutionizing uro-oncology care. Future research should prioritize developing comprehensive applications that address a broader range of urological cancers, enhance patient–clinician communication, and undergo rigorous evaluation. Collaborative efforts among researchers, clinicians, and app developers are crucial to overcome existing limitations and maximize the potential of these innovative healthcare tools.
目的：本系统综述旨在评估移动健康（mHealth）应用程序在泌尿肿瘤学领域的应用价值，重点探讨其在改善泌尿生殖系统癌症患者护理、症状管理和医患沟通方面的潜力。 方法：遵循系统综述和荟萃分析优先报告项目（PRISMA）指南，对面向泌尿生殖系统癌症患者的移动健康应用程序进行全面系统综述。 结果：综述共纳入29项研究，分析表明移动健康应用程序在泌尿肿瘤患者护理中展现出应用潜力。主要发现包括有效的症状监测、增强的决策支持以及改善的患者教育。研究证实该类应用程序具有可行性且患者接受度良好，但同时也发现实施过程中存在技术障碍、应用程序质量参差不齐以及数字医疗技术可及性不均等挑战。本综述将移动健康干预措施系统归纳为症状管理、决策支持和个性化护理三大功能领域，并识别出数字不平等、偏倚风险高及应用程序质量差异等关键实施障碍。 结论：移动健康应用程序有望革新泌尿肿瘤诊疗模式。未来研究应重点开发覆盖更广泛泌尿系统癌种、强化医患沟通功能并经过严格评估的综合性应用程序。研究人员、临床医生和应用程序开发者需加强协作，以克服现有局限，充分发挥这些创新医疗工具的应用潜力。
The Role of mHealth Applications in Uro-Oncology: A Systematic Review and Future Directions
肿瘤(癌症)患者之家